Reforming the cancer drug fund

BMJ. 2014 Nov 28:349:g7276. doi: 10.1136/bmj.g7276.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / economics*
  • Cost-Benefit Analysis*
  • Financial Management / economics*
  • Health Expenditures*
  • Humans
  • Neoplasms / drug therapy*
  • State Medicine / economics*
  • United Kingdom

Substances

  • Antineoplastic Agents